Cannabis Sativa: A Budding Therapy for Dementia

When: Wednesday, 14 Jun 2023

Time: 7 pm (AEST)

Cost: Free

The webinar has ended.

However, you can watch the recording in the Medihuanna Community.

Join Associate Professor Genevieve Steiner-Lim in an exclusive webinar presented by NICM Health Research Institute, Western Sydney University, focusing on Cannabis sativa: A budding therapy for dementia.

Prof Genevieve Steiner-Lim

Associate Professor Genevieve Steiner-Lim, an NHMRC Emerging Leadership Fellow and the Clinical Research Platform Lead at NICM Health Research Institute, has dedicated her career to the early detection, prevention, and treatment of cognitive decline in older adults.

Her ultimate aim is to reduce the risk of dementia and improve the quality of life for this population. A/Prof Steiner-Lim is currently involved in groundbreaking research testing novel therapeutics for early-stage Alzheimer’s disease intervention, including a world-first medicinal cannabis trial.

In this webinar, A/Prof Steiner-Lim will:

  • Delve into the looming problem of dementia as a leading cause of disability in Australians aged 65 years and over, and the urgency of finding new therapeutic solutions given the high failure rate of Alzheimer’s disease drugs.
  • Explain the potential therapeutic properties of Cannabis sativa L., which contains over 100 phytocannabinoids and other compounds that may help address multiple aspects of dementia pathophysiology and assist with clinical management.
  • Provide an overview of the current preclinical and clinical evidence on medicinal cannabis for dementia, underscoring the potential of this plant as a novel approach to dementia therapy.
  • Discuss her team's innovative approach to a new clinical trial using a CBD-rich cannabis formulation as a potential solution for early-stage Alzheimer’s disease.

Join us for this insightful webinar as A/Prof Steiner-Lim shares her expert knowledge on the potential of Cannabis sativa as a budding therapy for dementia.

Engage with us in this critical conversation and explore the potential of medicinal cannabis in dementia management.

Claim CPD Hours

Medihuanna is a CPD approved education provider, and this activity has been approved by the RACGP (Activity ID: 518521). Upon completing this activity, you will be eligible to claim CPD hours. The activity will include the following CPD allocation which will be uploaded to the RACGP dashboard.

Educational Activity: 1 hour

CPD Accredition Provider badge

© Medihuanna Pty Ltd, 2023. All rights reserved.